Cepheid Reagents and Consumables BPA

The Indian Health Service seeks to establish a Blanket Purchase Agreement for Cepheid molecular diagnostic reagent test kits and consumables, with proposals due September 14. The procurement is set aside for Indian Small Business Economic Enterprises under the Buy Indian Act, requiring offerors to maintain Indian Economic Enterprise eligibility at proposal submission, award, and throughout the full performance period.

Place of performance is Lawton, Oklahoma. The contractor shall supply five reagent kit types—XPRS4PLEX (1,627 units annually), GXCT/NG-10 (1,306 units annually), GXTV-10 (1,624 units annually), XPRSTREPA-10 (1,725 units annually), and GXCDIFF/EPI-10 (84 units annually)—for the Cepheid Genexpert Analyzer, with volumes including a 40% increase for quality control, proficiency testing, and validation studies. The contract period consists of a 12-month base year with four optional 12-month renewal years (2026–2031).

All products must be manufactured and shipped in accordance with CLIA '88 and FDA regulations for clinical laboratory use. The contractor must designate a single point of contact empowered to make daily decisions, provide a toll-free service number staffed 8:00 a.m. to 4:30 p.m. Monday through Friday, coordinate deliveries to 1515 Lawrie Tatum Road with no deliveries after 4:15 p.m., and provide installation instructions, warranty documents, and product specifications. Special requirements include compliance with security clearance guidance, maintenance of a tobacco/smoke-free environment, confidentiality of facility operations, and adherence to facility security protocols including valid identification and authorized escort procedures. The NAICS code is 325413, In-Vitro Diagnostic Substance Manufacturing; PSC is 6640, Laboratory Equipment and Supplies.